EMBL-EBI | Chemical Biology | ChEBI

Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search

CHEBI:28574 - α-GalNAc-(1→3)-[α-Fuc-(1→2)]-β-Gal-(1→3)-α-GalNAc-(1→3)-[α-Fuc-(1→2)]-β-Gal-(1→4)-β-GlcNAc-(1→3)-β-Gal-(1→4)-β-Glc-(1→1')-Cer

ChEBI IDCHEBI:28574
ChEBI Nameα-GalNAc-(1→3)-[α-Fuc-(1→2)]-β-Gal-(1→3)-α-GalNAc-(1→3)-[α-Fuc-(1→2)]-β-Gal-(1→4)-β-GlcNAc-(1→3)-β-Gal-(1→4)-β-Glc-(1→1')-Cer
Stars
ASCII Namealpha-GalNAc-(1->3)-[alpha-Fuc-(1->2)]-beta-Gal-(1->3)-alpha-GalNAc-(1->3)-[alpha-Fuc-(1->2)]-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1->1')-Cer
DefinitionA glycononaosylceramide in which the sugar component is a linear heptasaccharide made up from galactose, N-acetylgalactosamine, glucose and N-acetylglucosamine residues, branched with L-fucosyl residues at two of the galactose residues in the chain.
Secondary ChEBI IDsCHEBI:9796, CHEBI:22089
Last Modified2 December 2019
DownloadsMolfile
FormulaC79H135N4O46R
Net Charge0
Average Mass (excl. R groups)1876.916
Monoisotopic Mass (excl. R groups)1875.83475
SMILES*C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@H]5O[C@H](CO)[C@H](O)[C@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@H]7O[C@H](CO)[C@H](O)[C@H](O)[C@H]7NC(C)=O)[C@H]6O[C@@H]6O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]6O)[C@H]5NC(C)=O)[C@H]4O[C@@H]4O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]4O)[C@H](O)[C@H]3NC(C)=O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC
Species of MetaboliteComponentSourceComments
Mus musculus (ncbitaxon:10090) - PubMed (19425150) Source: BioModels - MODEL1507180067
Roles Classification
Biological Role:
mouse metabolite  Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
ChEBI Ontology
Outgoing Relation(s)
α-GalNAc-(1→3)-[α-Fuc-(1→2)]-β-Gal-(1→3)-α-GalNAc-(1→3)-[α-Fuc-(1→2)]-β-Gal-(1→4)-β-GlcNAc-(1→3)-β-Gal-(1→4)-β-Glc-(1→1')-Cer (CHEBI:28574) has role mouse metabolite (CHEBI:75771)
α-GalNAc-(1→3)-[α-Fuc-(1→2)]-β-Gal-(1→3)-α-GalNAc-(1→3)-[α-Fuc-(1→2)]-β-Gal-(1→4)-β-GlcNAc-(1→3)-β-Gal-(1→4)-β-Glc-(1→1')-Cer (CHEBI:28574) is a N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→3)-N-acetyl-α-D-galactosaminyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide (CHEBI:144479)
α-GalNAc-(1→3)-[α-Fuc-(1→2)]-β-Gal-(1→3)-α-GalNAc-(1→3)-[α-Fuc-(1→2)]-β-Gal-(1→4)-β-GlcNAc-(1→3)-β-Gal-(1→4)-β-Glc-(1→1')-Cer (CHEBI:28574) is a fucosyl oligoglycosylceramide (CHEBI:24121)
α-GalNAc-(1→3)-[α-Fuc-(1→2)]-β-Gal-(1→3)-α-GalNAc-(1→3)-[α-Fuc-(1→2)]-β-Gal-(1→4)-β-GlcNAc-(1→3)-β-Gal-(1→4)-β-Glc-(1→1')-Cer (CHEBI:28574) is a glycononaosylceramide (CHEBI:36643)
IUPAC Name 
N-[(2S,3R,4E)-1-{[2-acetamido-2-deoxy-α-D-galactopyranosyl-(1→3)-[6-deoxy-α-L-galactopyranosyl-(1→2)]-β-D-galactopyranosyl-(1→3)-2-acetamido-2-deoxy-α-D-galactopyranosyl-(1→3)-[6-deoxy-α-L-galactopyranosyl-(1→2)]-β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide
Synonyms  Source
Type IIIA glycolipidKEGG GLYCAN
Blood group type 3 chain AChEBI
α-GalNAc-(1→3)-[α-Fuc-(1→2)]-β-Gal-(1→3)-α-GalNAc-(1→3)-[α-Fuc-(1→2)]-β-Gal-(1→4)-β-GlcNAc-(1→3)-β-Gal-(1→4)-β-Glc-CerChEBI
α-D-GalNAc-(1→3)-[α-L-Fuc-(1→2)]-β-D-Gal-(1→3)-α-D-GalNAc-(1→3)-[α-L-Fuc-(1→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1→1')-CerChEBI
α-D-GalpNAc-(1→3)-[α-L-Fucp-(1→2)]-β-D-Galp-(1→3)-α-D-GalpNAc-(1→3)-[α-L-Fucp-(1→2)]-β-D-Galp-(1→4)-β-D-GlcpNAc-(1→3)-β-D-Galp-(1→4)-β-D-Glcp-CerChEBI
α-D-GalNAc-(1→3)-[α-L-Fuc-(1→2)]-β-D-Gal-(1→3)-α-D-GalNAc-(1→3)-[α-L-Fuc-(1→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-CerChEBI
UniProt Name  Source
a neolactoside IV3-α-[GalNAc-α-(1→3)-(Fuc-α-(1→2))-Gal-β-(1→3)-GalNAc], IV2-α-Fuc-nLc4Cer(d18:1(4E))UniProt
Manual XrefsDatabases
G00059KEGG GLYCAN
Citations